About
Korsana Biosciences develops blood-brain barrier-penetrant delivery technology and therapeutic candidates for neurodegenerative diseases, focusing on enhancing central nervous system drug exposure with its THETA™ shuttle platform and advancing treatments for Alzheimer's disease.
Explore Korsana Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.